Defibrotide
Unknown
Overview
Defibrotide is a unknown active pharmaceutical ingredient (ChEMBL CHEMBL2108396).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Defibrotide expires 22 Jun 2032. Generic API sourcing typically opens up once these lapse.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.